Predicting influenza outbreak using Fitbit wearable technology
Focus:
-
![MyndYou Allscripts partnership]()
MyndYou and Allscripts partner on AI triage for high-risk patients
-
![foetal monitoring]()
Q&A: the challenge of foetal monitoring with Professor Barrie Hayes-Gill
-
![Empatica mars wearable]()
Empatica unveils wearable monitor for mission to Mars
-
![alzheimers ipad test]()
Medopad partners with Janssen on digital memory test
-
![fertility tracking devices]()
Cashing in on fertility: should femtech receive more scrutiny?
-
![Abbott and Omada Health to offer personalised diabetes care]()
Abbott and Omada Health to offer personalised diabetes care
Most Read
- MyndYou and Allscripts partner on AI triage for high-risk patients
- Q&A: the challenge of foetal monitoring with Professor Barrie Hayes-Gill
- Empatica unveils wearable monitor for mission to Mars
- Medopad partners with Janssen on digital memory test
- Cashing in on fertility: should femtech receive more scrutiny?
Latest Content
Medtronic reveals results for DTM Spinal Cord Stimulation trial
Medtronic has revealed three-month results from a multicentre randomised controlled trial (RCT) comparing differential target multiplexed (DTM) spinal cord stimulation (SCS) therapy using its Intellis platform with conventional SCS therapy.
MyndYou and Allscripts partner on AI triage for high-risk patients
Artificial intelligence (AI) company MyndYou has made its triaging and care management solution available to electronic health record technology firm Allscripts’ clients.
Medtronic acquires digital health startup Klue
Irish medical device maker Medtronic has acquired Klue, a US-based digital health startup, focused on behaviour tracking and change.
Anixa Biosciences launches AI-driven prostate cancer detection test
US-based Anixa Biosciences has commercially launched Cchek Prostate Cancer Confirmation (Cchek PCC) test.
Eli Lilly strengthens alliance with Dexcom for insulin devices
Eli Lilly has reached a deal to integrate DexCom’s continuous glucose monitoring (CGM) into its personalised diabetes management system.
Takeda to expand use of MiTest Health Crohn’s risk prediction tool
Takeda Pharmaceuticals USA has entered an exclusive partnership with MiTest Health to expand the use of its Crohn's disease risk (CD) prediction tool.
Researchers find blood test to identify rare breast cancer mutations
Researchers from Cancer Research UK have found that a blood test could quickly identify rare mutations in patients with advanced breast cancer.
Israeli health tech firms merge to advance AI-powered biomarkers
Israel-based artificial intelligence (AI) startups Beyond Verbal and Healthymize, which both make diagnoses through voice analyses, have merged operations to create an entity, Vocalis Health.
Beta Bionics receives breakthrough designation for blood sugar device
Beta Bionics has secured breakthrough device designation status from the US Food and Drug Administration (FDA) for its iLet Bionic Pancreas System.
Latest News
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.
Close
Close
Close
Go Top